1,253
Views
2
CrossRef citations to date
0
Altmetric
Arctic Military Conference in Cold Weather Medicine

Botulinum Toxin A in the treatment of frostbite sequelae – results from a blinded, early-phase, comparative trial

ORCID Icon, , ORCID Icon, , & ORCID Icon
Article: 2189556 | Received 05 Jan 2023, Accepted 07 Mar 2023, Published online: 15 Mar 2023

References

  • Guly H. History of accidental hypothermia. Resuscitation. 2011;82(1):122–10.
  • Golden FS, Francis TJ, Gallimore D, et al. Lessons from history: morbidity of cold injury in the Royal Marines during the Falklands Conflict of 1982. Extrem Physiol Med. 2013;2(1):23.
  • Norheim AJ, Borud E. Frostbite in the Norwegian Armed Forces. Tidsskrift for den Norske laegeforening. 2018;138(14). DOI:10.4045/tidsskr.17.1070
  • Imray C, Grieve A, Dhillon S, et al. Cold damage to the extremities: frostbite and non-freezing cold injuries. Postgrad Med J. 2009;85(1007):481–488.
  • Ervasti O, Hassi J, Rintamaki H, et al. Sequelae of moderate finger frostbite as assessed by subjective sensations, clinical signs, and thermophysiological responses. Int J Circumpolar Health. 2000;59(2):137–145.
  • Steinberg T, Norheim AJ, Bjerkan G, et al. Freezing cold injuries among soldiers in the Norwegian Armed Forces - a cross sectional study. Int J Circumpolar Health. in press;2023.
  • Norheim AJ, Sulliwan-Kwantes W, Steinberg T, et al., The classification of freezing cold injuries - a NATO research task group position paper. Int J Circumpolar Health. 81: In press. 2022; 10.1080/22423982.2022.2049491.
  • Handford C, Buxton P, Russell K, et al. Frostbite: a practical approach to hospital management. Extrem Physiol Med. 2014;3:7.
  • Van Beek AL, Lim PK, Gear AJ, et al. Management of vasospastic disorders with botulinum toxin a. Plast Reconstr Surg. 2007;119(1):217–226.
  • Norheim AJ, Mercer J, Musial F, et al. A new treatment for frostbite sequelae; Botulinum toxin. Int J Circumpolar Health. 2017;76(1):1273677.
  • Forsvarets helsregister. Available from: https://helsedata.no/no/forvaltere/forsvarsdepartementet/forsvarets-helseregister/
  • Forskrift om innsamling og behandling av opplysninger i Forsvarets helseregister. Available from: https://lovdata.no/dokument/SF/forskrift/2005-09-02-1010
  • Iorio ML, Masden DL, Higgins JP. Botulinum toxin a treatment of Raynaud’s phenomenon: a review. Semin Arthritis Rheum. 2012;41(4):599–603.
  • Ring EF, Ammer K. Infrared thermal imaging in medicine. Physiol Meas. 2012;33(3):R33–46.
  • Moreira DG, Costello JT, Brito CJ, et al. Thermographic imaging in sports and exercise medicine: a Delphi study and consensus statement on the measurement of human skin temperature. J Therm Biol. 2017;69:155–162.
  • Maier C, Baron R, Tölle T, et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain. 2010;150(3):439–450.
  • Magerl W, Krumova EK, Baron R, et al. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain. 2010;151(3):598–605.
  • Pfau DB, Krumova EK, Treede RD, et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain. 2014;155(5):1002–1015. DOI:10.1016/j.pain.2014.02.004
  • EuroQol G. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
  • EQ-5D-3L. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/
  • Norheim AJ, Fønnebø VM, Lindeland JP, et al. Reflexology for acute rhinosinusitis–results from a blinded, early-phase comparative trial. EXPLORE. 2022;19:36–41.
  • Engen DJ, Wahner-Roedler DL, Nadolny AM, et al. The effect of chair massage on muscular discomfort in cardiac sonographers: a pilot study. BMC Complement Altern Med. 2010;10:50.
  • Aickin M. Separation tests for early-phase complementary and alternative medicine comparative trials. Evid-Based Integr Med. 2004;1(4):225–231.
  • Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain. 2006;123(3):231–243.
  • Regli IB, Strapazzon G, Falla M, et al. Long-Term sequelae of frostbite—A scoping review. Int J Environ Res Public Health. 2021;18(18):9655.
  • de Villeneuve Bargemon J-B, Prenaud C. Comment to: frostbite of the extremities–recognition, evaluation and treatment: frostbite and botulinum toxin a. Injury. 2022;53(12):4159.
  • Eleopra R, Rinaldo S, Montecucco C, et al. Clinical duration of action of different botulinum toxin types in humans. Toxicon. 2020;179:84–91.
  • Marvulli R, Ranieri M, Rizzo LB, et al. Clinical onset of action of incobotulinum toxin a preparation. CNS Neurol Disord Drug Targets. 2022;22:916–923. DOI:10.2174/1871527321666220630154404.
  • Jeynes LC, Gauci CA. Evidence for the use of botulinum toxin in the chronic pain setting—a review of the literature. Pain Pract. 2008;8(4):269–276.
  • Neumeister MW. Botulinum toxin type a in the treatment of Raynaud’s phenomenon. J Hand Surg. 2010;35(12):2085–2092.
  • Rossetto O, Pirazzini M, Montecucco C. Current gaps in basic science knowledge of botulinum neurotoxin biological actions. Toxicon. 2015;107:59–63.
  • Segreto F, Marangi GF, Cerbone V, et al. The role of botulinum toxin a in the treatment of raynaud phenomenon. Ann Plast Surg. 2016;77(3):318–323.
  • Baron R, Maier C, Attal N, et al. Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain. 2017;158(2):261–272. DOI:10.1097/j.pain.0000000000000753
  • Blume KR, Racz J, Franz M, et al. Quantitative sensory testing after macroreplantation: evidence for a specific somatosensory profile. Pain. 2018;159(7):1289–1296.
  • Aickin M. The importance of early phase research. J Altern Complement Med. 2007;13(4):447–450.